Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 31.3% – Time to Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s stock price fell 31.3% during trading on Thursday . The company traded as low as C$0.14 and last traded at C$0.17. 1,643,425 shares traded hands during mid-day trading, an increase of 198% from the average session volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Down 31.3 %

The firm has a fifty day moving average price of C$0.10 and a 200 day moving average price of C$0.07. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The firm has a market capitalization of C$23.01 million, a price-to-earnings ratio of -16.50 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.